BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38641672)

  • 1. The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling.
    Ma W; Zhang J; Chen W; Liu N; Wu T
    J Exp Clin Cancer Res; 2024 Apr; 43(1):117. PubMed ID: 38641672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression.
    Liu N; Zhang J; Chen W; Ma W; Wu T
    J Exp Clin Cancer Res; 2023 Oct; 42(1):263. PubMed ID: 37817227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
    Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
    Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
    Conboy CB; Yonkus JA; Buckarma EH; Mun DG; Werneburg NW; Watkins RD; Alva-Ruiz R; Tomlinson JL; Guo Y; Wang J; O'Brien D; McCabe CE; Jessen E; Graham RP; Buijsman RC; Vu D; de Man J; Ilyas SI; Truty MJ; Borad M; Pandey A; Gores GJ; Smoot RL
    J Hepatol; 2023 Jan; 78(1):142-152. PubMed ID: 36162702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
    Tóth M; Wehling L; Thiess L; Rose F; Schmitt J; Weiler SME; Sticht C; De La Torre C; Rausch M; Albrecht T; Grabe N; Duwe L; Andersen JB; Köhler BC; Springfeld C; Mehrabi A; Kulu Y; Schirmacher P; Roessler S; Goeppert B; Breuhahn K
    BMC Cancer; 2021 Oct; 21(1):1079. PubMed ID: 34615513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
    Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
    Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.
    Ilyas SI; Yamada D; Hirsova P; Bronk SF; Werneburg NW; Krishnan A; Salim W; Zhang L; Trushina E; Truty MJ; Gores GJ
    J Biol Chem; 2016 Apr; 291(15):8031-47. PubMed ID: 26826125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
    Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
    Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
    Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
    J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma.
    He M; Cheng C; Tu J; Ji SS; Lou D; Bai B
    J Int Med Res; 2021 May; 49(5):3000605211009722. PubMed ID: 34018826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP is a critical oncogene in human cholangiocarcinoma.
    Pei T; Li Y; Wang J; Wang H; Liang Y; Shi H; Sun B; Yin D; Sun J; Song R; Pan S; Sun Y; Jiang H; Zheng T; Liu L
    Oncotarget; 2015 Jul; 6(19):17206-20. PubMed ID: 26015398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
    Bai AH; Wu WK; Xu L; Wong SH; Go MY; Chan AW; Harbord M; Zhang S; Chen M; Wu JC; Chan MW; Chan MT; Chan FK; Sung JJ; Yu J; Cheng AS; Ng SC
    J Crohns Colitis; 2016 Jun; 10(6):726-34. PubMed ID: 26802082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
    Wu G; Wang Q; Wang D; Xiong F; Liu W; Chen J; Wang B; Huang W; Wang X; Chen Y
    Clin Transl Med; 2023 Dec; 13(12):e1502. PubMed ID: 38050190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression.
    Zhu B; Zheng J; Hong G; Bai T; Qian W; Liu J; Hou X
    Chin Med J (Engl); 2022 Dec; 135(24):2956-2967. PubMed ID: 36728287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.